Highlights and Quick Summary
- Ending Cash for the quarter ending June 30, 2023 was $-342 Million (a -179.4% decrease compared to previous quarter)
- Year-over-year quarterly Ending Cash increased by 191.22%
- Annual Ending Cash for 2022 was $643 Million (a 11.5% increase from previous year)
- Annual Ending Cash for 2021 was $576 Million (a -7.27% decrease from previous year)
- Annual Ending Cash for 2020 was $622 Million (a 269.94% increase from previous year)
- Twelve month Ending Cash ending June 30, 2023 was $373 Million (a -41.44% decrease compared to previous quarter)
- Twelve month trailing Ending Cash decreased by -9.77% year-over-year
Trailing Ending Cash for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $373 Million | $637 Million | $643 Million | $413 Million |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Ending Cash of Emergent Biosolutions Inc.
Most recent Ending Cashof EBS including historical data for past 10 years.Interactive Chart of Ending Cash of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Ending Cash for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-341.6 | $430.2 | – | – | – |
| 2022 | $401.6 | $-117.3 | $-77.7 | $436.0 | $642.6 |
| 2021 | $172.3 | $-43.7 | $-100.3 | $548.0 | $576.3 |
| 2020 | $206.3 | $146.2 | $87.3 | $181.7 | $621.5 |
| 2019 | $28.6 | $-38.2 | $40.2 | $137.4 | $168.0 |
| 2018 | $-228.0 | $149.1 | $26.7 | $164.6 | $112.4 |
| 2017 | $-161.69 | $25.36 | $45.46 | $270.17 | $179.3 |
| 2016 | $-27.43 | $-34.46 | $-7.62 | $341.02 | $271.5 |
| 2015 | $4.08 | $93.88 | $-1.67 | $216.52 | $312.8 |
| 2014 | $38.25 | $74.12 | $7.92 | $160.22 | $280.5 |
| 2013 | $6.78 | $16.32 | $26.01 | $130.24 | $179.34 |
| 2012 | $-56.24 | $36.06 | – | – | $141.67 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic